Press

Press Room

The press room offers you direct access to Candriam's most recent news and press releases: results, strategic partnerships, fund launches, communication on our philanthropic initiatives, etc., as well as the main news articles available.

Press Release

  • Month
  • Year
  • Country

Belfius and Candriam Strenghten Long-Term Strategic Partnership

Renewed partnership will expand Belfius client access to Candriam's international expertise, including private markets, and accelerate Belfius Bank's ambition to become the leading private bank in Belgium.

World’s Greenest Football Club, Forest Green Rovers, Renews International Partnership with Sustainable Investment Organisation – Candriam

Forest Green Rovers, recognised globally as the greenest football club, is pleased to announce an extension of its international partnership with Candriam, a leading sustainable asset management firm. This continued collaboration emphasises both organisations' commitment to sustainability, social impact, and community-focused initiatives.

Candriam Reports Strong 2024 Performance with Continued Growth in AUM and Strategic Expansion

Candriam, a global multi-asset manager and a leader in sustainable investing, has reported strong performance in 2024, with total assets under management (AUM) increasing to €155 billion , up from €145 billion at the end of 2023. Sustainability-related assets represent 75% of total AUM, equivalent to €116 billion . Additionally, 44% of Candriam’s funds were awarded a 4-5 Morningstar rating, reflecting consistent long-term performance.
Loading...
  • Snapshot of Candriam

    General information on Candriam with keyfigures, updated every semester.

  • Library in the spotlight

    Discover our Candriam publications here!

Latest Insights

  • Healthcare, ESG, SRI

    Why healthcare, why now?

    On Tuesday, September 30, the pharmaceutical industry issued its first formal response to President Trump’s recent letter on drug pricing, announcing a deal between Pfizer and the US administration.
  • ESG, SRI, Oncology, Healthcare

    From uncertainty to growth: why invest in healthcare?

    As we enter the month of October, investors are faced with an obvious question: is the time right for new investments in the oncology sector? Pasquale Sansone, Senior Biotechnology Analyst, shares his analysis and convictions.
  • Private Debt

    Private Debt: The Lower-Mid-Market Niche

    The lower-mid-market segment of Private Debt offers potentially attractive returns and the ability to manage risk through greater selectivity and better control. Yet, success requires experience and market presence.
  • Fixed Income, Charudatta Shende

    Bond market opportunities: The Return of Slope

    The global rates landscape is entering a decisive new phase as the long-standing flatness of yield curves gives way to steepness that has not been seen since 2011. The term premium, the additional interest by bondholders investing in longer-dated bonds versus short-term bonds, is back after an absence of many years.
  • ESG, SRI

    Active Ownership: Persistence Pays

    If some elements of our annual 2024 Annual Engagement and Voting Review sound familiar, that’s no coincidence. To maximize our impact, we focus on long-term core topics. Engagement and voting are central to our investment process, extending beyond the important responsibility of the investments we already hold.
  • Nadège Dufossé, Asset Allocation

    Europe: From Early Lead to Inflection

    From January through the end of May, European equities reclaimed leadership. In local currency, the MSCI EMU beat the MSCI World by roughly six to seven percentage points, and the quality of that advance was unmistakably value-tilted: banks and insurers led from the front, with telecom services, utilities and industrials providing consistent breadth.

Find it fast

Get information faster with a single click

Get insights straight to your inbox